World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 February 2024
Main ID:  NCT02536118
Date of registration: 17/08/2015
Prospective Registration: No
Primary sponsor: Medtronic
Public title: Micra Transcatheter Pacing System Post-Approval Registry
Scientific title: Micra Transcatheter Pacing System Post-Approval Registry
Date of first enrolment: July 2015
Target sample size: 3100
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/ct2/show/NCT02536118
Study type:  Observational [Patient Registry]
Study design:   
Phase: 
Countries of recruitment
Belgium Canada Czech Republic Czechia Denmark France Germany Greece
Hungary Iceland Israel Italy Japan Kuwait Netherlands New Zealand
Norway Poland Portugal Russian Federation Saudi Arabia Slovenia Spain Sweden
Switzerland United Arab Emirates United Kingdom United States
Contacts
Name:     Micra Registry Manager
Address: 
Telephone:
Email:
Affiliation:  Medtronic
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patient or legally authorized representative provides written authorization and/or
consent per institution and geographical requirements

- Patient is intended to receive or be treated with a Micra Transcatheter Pacing System
and must be enrolled prior to the TPS implant procedure

Exclusion Criteria:

- Patient who is, or is expected to be inaccessible for follow-up

- Patient with exclusion criteria required by local law

- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or
device study that may confound results



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Bradycardia
Intervention(s)
Device: Micra Transcatheter Pacing System
Primary Outcome(s)
Long-term complication free survival [Time Frame: 9 years]
Acute complication rate [Time Frame: 30-days]
Secondary Outcome(s)
Confirm the rate response operation of the Micra system [Time Frame: Approximately 2 years]
Estimate System Longevity [Time Frame: Up to 9 years]
Pacing impedance (ohms) and pacing threshold (volts) [Time Frame: Up to 9 years]
Complications stratified by implant type [Time Frame: Up to 9 years]
Estimate Micra System revision rate [Time Frame: Up to 9 years]
Secondary ID(s)
Micra Registry
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history